Loading page…

Ivp Limited (IVP) · mywealthgrid

About

Specialty chemicals player in materials sector, ₹183 Cr market cap. Recent quarters show ₹145–165 Cr revenue with volatile margins (3–13% OPM). Trades PE 5.82; 71% promoter, minimal institutional ownership.

Face value: ₹10

Market cap

₹232 Cr

P/E

7.3×

P/B

1.5×

Dividend yield

0.7%

ROE

12.6%

ROCE

22%

Debt / equity

0.42

OPM

5.8%

EPS (TTM)

₹30.5

Book value

₹152.1

52-week high

₹230.8

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Margin volatility: OPM ranged 3.08% (Jun 2025) to 13.31% (Jun 2026)—verify whether improvement is structural or cyclical

Revenue flat over 8 quarters (₹122–164 Cr range) with no growth—check if industry headwind or company-specific constraint

Thin baseline OPM (5.84%) leaves little buffer—verify competitive position, customer concentration, and pricing power in specialty vs. commodity segments

Illiquid: 0% FII, 0.02% DII in ₹183 Cr market cap may impair trading and capital-raising ability

Generated analysis · source review pending

Growth drivers

Margin recovery: OPM jumped from 3.08% (Jun 2025) to 13.31% (Jun 2026)—verify if structural improvement or temporary factors (volume/mix/pricing)

EPS growth: ₹1.15 (Jun 2025) to ₹13.57 (Jun 2026)—entirely dependent on margin persisting above 10%

Revenue stabilization: ₹145–165 Cr range in recent quarters vs. ₹122 Cr trough (Sep 2024) suggests demand stabilized—verify if platform for margin-driven profit growth

Generated analysis · source review pending

₹224.8+42.2%1Y

Beta

1.23

Amplifies index moves

Volatility (1y)

44.3%

Annualised, daily returns

RSI (14)

57.5

Neither overbought nor oversold

Rel. strength (1y)

29.1%

Ahead of the market

Beta is measured against NIFTY 50 over three years of weekly returns — 1 moves with the index, above 1 amplifies it, below 1 damps it.

Quick read

rule-based

Pros

+Profit CAGR of 32.9% over the last 5 years
+Revenue CAGR of 15.5% over the last 5 years
+High promoter holding of 71.3% with no pledge
+Outperformed the universe by 29.1% over 1 year

Cons

−Low return on equity of 10.3% (3-yr avg)
−Thin operating margin of 5.8%
−Low dividend payout of 4.9% of profit

Research score

Structured signal from quality, growth, valuation and momentum.

67/100

Business quality: 39
Growth: 39

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM	₹47,713 Cr	₹49,912 Cr	₹5,303 Cr	₹1,375 Cr	25.8%	₹615 Cr	11.5%	11.1%	7.6%	401
Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR	₹41,740 Cr	₹42,967 Cr	₹3,634 Cr	₹1,232 Cr	32.6%	₹790 Cr	20%	21.6%	20.1%	61
Aether Industries LimitedAETHERAETHER	₹22,161 Cr	₹22,603 Cr	₹1,224 Cr	₹384 Cr	31.3%	₹235 Cr	19.8%	13.2%	9.4%	330
Atul LimitedATULATUL	₹17,231 Cr	₹17,411 Cr	₹6,643 Cr	₹1,189 Cr	16.4%	₹704 Cr	11%	14.1%	11.5%	70
Aarti Industries LimitedAARTIINDAARTIIND	₹16,869 Cr	₹21,790 Cr	₹9,012 Cr	₹1,337 Cr	14.1%	₹531 Cr	5.1%	8.8%	7.3%	54
Fine Organic Industries LimitedFINEORGFINEORG	₹15,752 Cr	₹15,797 Cr	₹2,472 Cr	₹535 Cr	20.4%	₹438 Cr	17.6%	21.6%	16.8%	113
Basf India LimitedBASFBASF	₹14,796 Cr	₹14,796 Cr	₹16,177 Cr	₹952 Cr	4.4%	₹643 Cr	2.8%	14%	11.1%	40
Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL	₹13,970 Cr	₹14,980 Cr	₹2,671 Cr	₹666 Cr	25.2%	₹342 Cr	12.4%	27.7%	25.2%	158
Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM	₹13,546 Cr	₹13,694 Cr	₹676 Cr	₹233 Cr	34.6%	₹133 Cr	27.1%	31.1%	25.2%	366
Anupam Rasayan India LimitedANURASANURAS	₹13,243 Cr	₹15,058 Cr	₹2,535 Cr	₹563 Cr	22.2%	₹175 Cr	9.4%	9.1%	5.5%	377
Vinati Organics LimitedVINATIORGAVINATIORGA	₹12,528 Cr	₹12,528 Cr	₹2,381 Cr	₹665 Cr	29.4%	₹448 Cr	19.9%	18.8%	14.9%	152
Elantas Beck India LimitedELANTASELANTAS	₹10,644 Cr	₹10,644 Cr	₹778 Cr	₹147 Cr	20.3%	₹136 Cr	17.4%	20.6%	15.8%	70

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	154	51	51	320	229	290	557	661	546	539	595
COGS	-106	39	39	264	180	224	460	547	442	433	472
Gross profit	—	12	12	56	49	65	96	114	104	106	123
	246	8	8	47	49	49	61	74	76	80	88
	14	5	5	9	-0	16	35	40	28	25	35
OPM %	9%	9.4%	9.4%	2.9%	-0%	5.6%	6.3%	6%	5.1%	4.7%	5.8%
Depreciation	1	0	0	3	5	5	5	5	6	6	6
Interest	0	0	0	8	10	7	10	12	9	8	7
	5	-1	-1	2	2	2	3	16	3	4	4
Profit before tax	18	4	4	0	-13	7	23	38	17	15	25
Tax	8	1	1	-3	-4	2	6	10	4	4	6
Tax %	42.2%	37%	37%	-1,107.1%	-32.8%	32.6%	24.5%	26.2%	26.2%	25.9%	25.7%
	10	2	2	3	-9	5	18	28	12	11	19
PAT margin %	6.8%	4.3%	4.3%	1.1%	-3.8%	1.6%	3.2%	4.2%	2.3%	2.1%	3.1%
EPS (₹)	10.1	2.1	2.1	3.3	-8.3	4.4	17.1	27.1	11.9	11	18.1
EPS adjusted (₹)	—	—	2.1	3.3	-8.3	4.4	17.1	27.1	11.9	11	18.1
	19.8%	93.9%	93.9%	30.5%	—	23%	8.8%	5.5%	8.4%	9.1%	8.3%
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	10	10	10	10	10	10	10	10	10
Reserves	71	71	—	65	81	108	119	129	147
	78	143	—	122	157	120	89	104	65
	88	50	—	106	122	145	112	104	120
Total equity & liabilities	247	275	—	304	371	384	331	348	342
	41	55	82	77	74	73	71	72	67
CWIP	17	27	—	0	0	2	2	0	1
Investments	0	0	—	3	3	0	0	0	0
	188	193	—	224	293	309	258	275	273
Total assets	247	275	—	304	371	384	331	348	342

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	17.6%	21.5%	22.5%	17.3%	17.2%	19%	19.6%	20.7%

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	71.32%	71.32%	71.32%	71.32%	71.32%	71.32%	71.32%	71.32%	71.32%	71.32%	71.32%	71.32%
FII	0.01%	0.04%	0%	0.01%	0%	0%	0%	0%	0%	0%	0%	0%
	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	28.65%	28.62%	28.66%	28.65%	28.66%	28.66%	28.66%	28.66%	28.66%	28.66%	28.66%	28.66%
No. of shareholders	—	—	—	—	—	—	—	—	7,095	7,072	6,961	6,912

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Ivp Limited. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

62 announcementsExport CSV

9 Sept 2026, 2:42 pmCompany Update

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 - Update On Fraud By Employee Of The Company

General PDF

31 Aug 2026, 5:41 pmCompany Update

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 - Update On Litigation/Dispute Before The Hon'Ble Bombay High Court.

General PDF

24 Aug 2026, 5:07 pmCompany Update

Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation PDF

27 Jul 2026, 6:01 pmBoard Meeting

Board Meeting Intimation for Board Meeting Scheduled To Be Held On Thursday, August 6, 2026

Exchange filing PDF

25 Jul 2026, 3:42 pmCompany Update

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 - Update On Order Passed By Office Of Estate Officer, Mumbai Port Trust ('MBPT').

General PDF

22 Jul 2026, 5:55 pmCompany Update

Communication To Shareholders - Intimation Of Tax Deduction On Dividend

General PDF

14 Jul 2026, 4:34 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

13 Jul 2026, 7:22 pmCorp. Action

Intimation Of Record Date For Payment Of Dividend, If Declared At The AGM For The Financial Year 2025-26

Record Date PDF

Date	Category	Subject	Filing
9 Sept 2026, 2:42 pm	Company Update General	Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 - Update On Fraud By Employee Of The Company	PDF
31 Aug 2026, 5:41 pm	Company Update General	Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 - Update On Litigation/Dispute Before The Hon'Ble Bombay High Court.

Loading announcements…

15 deals · 11 Feb 2022 – 6 Jul 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
6 Jul 2026	INDRA KIRAN VENTURES	Bulk	NSE	Buy	93,802	₹193.10	₹1.81 Cr
6 Jul 2026	INDRA KIRAN VENTURES	Bulk	NSE	Sell	62,070	₹192.64	₹1.20 Cr
21 Nov 2024	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	82,244	₹255.75	₹2.10 Cr
21 Nov 2024	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	82,244	₹255.26	₹2.10 Cr
28 Apr 2023	JAIN HARDIK INDRAMAL	Bulk	NSE	Buy	98,978	₹167.75	₹1.66 Cr
18 Feb 2022	MUSIGMA SECURITIES	Bulk	NSE	Sell	85,679	₹186.78	₹1.60 Cr
18 Feb 2022	MUSIGMA SECURITIES	Bulk	NSE	Buy	85,679	₹186.72	₹1.60 Cr
18 Feb 2022	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	61,787	₹189.82	₹1.17 Cr
18 Feb 2022	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	61,787	₹189.67	₹1.17 Cr
17 Feb 2022	SHARAD AGRAWAL	Bulk	NSE	Buy	63,316	₹172.50	₹1.09 Cr

1–10 of 15

1 / 2

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	5	-30	-27	56	-14	-21	41	45	-2	53
	-24	-28	-28	-5	-0	-3	10	-3	-5	-3
	7	58	54	-54	16	23	-51	-41	6	-48
Net cash flow	-11	-0	—	-3	1	-1	-0	1	-1	2
Free cash flow	-19	-58	-55	51	-15	-24	35	42	-7	50
CFO / Operating profit %	103.6%	-634.4%	-285.3%	—	-86.9%	-59.2%	102.4%	163.1%	-9.8%	151.9%

Working capital
Receivable days	140	—	175	137	115	115	123	114

Leverage
Current ratio	0.95	—	0.95	1.05	1.18	1.29	1.32	1.47

Return ratios
Return on assets %	1.2%	—	1.5%	4.8%	7.3%	3.7%	3.3%	5.5%

Ivp Limited

Ivp Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Announcements

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

18

1

Compounded sales growth

Compounded profit growth

Stock price CAGR

Return on equity

Ivp Limited

Ivp Limited

About

Key insights

Key risks

Growth drivers

Risk & technicals

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Announcements

Not in the F&O segment

No fund holdings on record

Announcements

Ratio timeline

Quarterly record

Annual reports

Dividends18

Board meetings1

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Stock price CAGR

Return on equity

18

1